Alseres Pharmaceuticals Financial Market Data
| Last Close 20-Aug-2008 |
$2.18 |
Price/ Sales Ratio |
-- |
| 52-Week High |
$3.50 |
Price/ Book Ratio |
-- |
| 52-Week Low |
$1.95 |
Price/ Earnings Ratio |
-- |
| 60-Month Beta |
1.1 |
Price/ Cash Flow Ratio |
-- |
| Market Cap (mil.) |
$45.4 |
Return on Assets |
(438.6%) |
| Shares Outstanding (mil.) |
20.8 |
Return on Equity |
88.2% |
| Dividend Rate |
-- |
Current Ratio |
1.45 |
| Dividend Yield |
-- |
Long-Term Debt/Equity |
-- |
| # of Institutional Holders |
13 |
% Owned by Institutions |
4.0% |
| Latest Short Interest Ratio |
-- |
Latest Net Insider Transactions |
-- |
| Revenue Growth |
0.0% |
0.0% |
0.0% |
| EPS Growth |
0.0% |
0.0% |
0.0% |
| Dividend Growth |
0.0% |
0.0% |
0.0% |
This data is provided as per license from EDGAR Online
